CGL10 Cagrilintide 10mg

CGL10 Cagrilintide 10mg is a synthetic research peptide belonging to the amylin analog class, structurally designed to replicate and enhance the activity of endogenous amylin, a hormone co-secreted with insulin after meals.

It primarily targets amylin and calcitonin receptor complexes in the brain and peripheral tissues, influencing key metabolic functions such as appetite suppression, gastric emptying delay, and post-meal glucose regulation.

Cagrilintide is widely studied in obesity and metabolic research due to its long-acting profile and ability to promote sustained satiety. It is often evaluated alone or in combination with GLP-1 receptor agonists in advanced metabolic studies.

Key research focus areas include:

• Appetite and hunger regulation pathways
• Energy intake reduction mechanisms
• Gastric emptying modulation
• Glucose and insulin response signaling
• Combination therapy research with incretin-based peptides

CGL10 Cagrilintide 10mg is intended strictly for laboratory research purposes and is not approved for human or veterinary use.